69980-11-6 Usage
Uses
Used in Pharmaceutical and Biomedical Research:
N-benzoyl-4-fluorophenylalanine is utilized as a precursor in the synthesis of various pharmaceuticals and peptides. Its unique structure and properties make it a crucial component in developing new drugs and therapeutic agents.
Used in Drug Development:
In the pharmaceutical industry, N-benzoyl-4-fluorophenylalanine is employed as a key building block for the creation of innovative drugs. The presence of the fluorine atom may enhance the compound's biological activity and pharmacokinetic properties, which can be leveraged to improve drug efficacy and safety.
Used in Peptide Synthesis:
N-benzoyl-4-fluorophenylalanine is also used in the synthesis of peptides, where it can introduce specific functionalities and modifications that are beneficial for the development of bioactive peptides and peptide-based drugs.
Overall, N-benzoyl-4-fluorophenylalanine is a versatile chemical compound with a wide range of applications in the pharmaceutical and biomedical fields, particularly in the development of new drugs and therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 69980-11-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,9,8 and 0 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 69980-11:
(7*6)+(6*9)+(5*9)+(4*8)+(3*0)+(2*1)+(1*1)=176
176 % 10 = 6
So 69980-11-6 is a valid CAS Registry Number.
69980-11-6Relevant academic research and scientific papers
Organocatalytic asymmetric [4+2] cyclization of 2-benzothiazolimines with azlactones: Access to chiral benzothiazolopyrimidine derivatives
Ni, Qijian,Wang, Xuyang,Xu, Fangfang,Chen, Xiaoyun,Song, Xiaoxiao
supporting information, p. 3155 - 3158 (2020/03/23)
An organocatalytic asymmetric domino Mannich/cyclization reaction between 2-benzothiazolimines with azlactones has been successfully developed. With the bifunctional squaramide catalyst, this formal [4+2] cyclization occurs with good to high yields and excellent stereoselectivities (up to 99% ee, >20?:?1 dr), providing an efficient and mild access to chiral benzothiazolopyrimidines bearing adjacent tertiary and quaternary stereogenic centers.
